Search

Author/Creator Kwakman, J.J.M.

2. Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group. (February 2017)

Authors:
Kwakman, J.J.M.; Simkens, L.H.J.; Van Rooijen, J.M.; Van de Wouw, A.J.; Loosveld, O.J.L.; Creemers, G.J.M.; Hendriks, M.P.; Los, M.; Van Alphen, R.J.; Polée, M.B.; Muller, E.W.; Van der Velden, A.M.T.; Van Voorthuizen, T.; Koopman, M.; Mol, L.; Van Werkhoven, E.; Punt, C.J.A.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗